Panacea Biotec Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
PANACEABIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Panacea Biotec has submitted a routine quarterly compliance certificate to NSE and BSE. The certificate, issued by its Registrar and Transfer Agent Skyline Financial Services on January 2, 2026, confirms compliance with SEBI's Regulation 74(5) for the quarter ended December 31, 2025. It certifies that physical share certificates received for dematerialization during the quarter were listed on stock exchanges and duly mutilated and cancelled within 15 days, with the depository's name recorded as the registered owner. The filing was signed by Ankit Jain, General Manager – Legal & Company Secretary. This is a standard procedural submission with no financial figures, business update, or corporate action disclosed.
This is a routine regulatory compliance filing required every quarter and has no bearing on the company's operations, financials, or stock price. Shareholders need not take any action.